MARKUPMADNESS.ORG KEYWORD DENSITY CHECKER

Total words: 2223 | 2-word phrases: 583 | 3-word phrases: 649 | 4-word phrases: 672

PAGE INFO

Title Try to keep the title under 60 characters (64 characters)
Markup Madness – Who’s Profiting from Your Prescription?
Description Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (14 characters)
Markup Madness

ONE WORD PHRASES 319 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1the4213.17%
2to288.78%
3medicines226.90%
4and216.58%
5generic216.58%
6for175.33%
7of113.45%
8aam113.45%
9resources92.82%
10generics92.82%

TWO WORD PHRASES 583 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1examples solutions81.37%
2top medicines71.20%
3medicines examples71.20%
4generic and61.03%
5biosimilar medicines61.03%
6solutions resources61.03%
7and biosimilar61.03%
8generic drug61.03%
9and the50.86%
10aam blog40.69%
11take a40.69%
12medicare part40.69%
13part d40.69%
14in the40.69%
15– the40.69%
16drug makers40.69%
17access to40.69%
18at the30.51%
19commonly prescribed30.51%
20act would30.51%

THREE WORD PHRASES 649 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1medicines examples solutions71.08%
2top medicines examples60.92%
3examples solutions resources60.92%
4generic and biosimilar50.77%
5and biosimilar medicines50.77%
6generic drug makers40.62%
7medicare part d40.62%
8in the supply30.46%
9from your prescription?30.46%
10profiting from your30.46%
11resources take action30.46%
12who’s profiting from30.46%
13medicaid generics penalty20.31%
14cash generic drug20.31%
15sell it to20.31%
16it to their20.31%
17follow the movement20.31%
18the supply chain20.31%
19commonly prescribed to20.31%
20makers sell it20.31%
21madness who’s profiting20.31%
22action top medicines20.31%
23solutions resources menu20.31%
24out on savings20.31%
25solutions resources take20.31%
26biosimilar medicines reduce20.31%
27take action top20.31%
28drug makers sell20.31%
29customers in the20.31%
30resources top medicines20.31%

FOUR WORD PHRASES 672 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1top medicines examples solutions60.89%
2medicines examples solutions resources50.74%
3generic and biosimilar medicines50.74%
4who’s profiting from your30.45%
5profiting from your prescription?30.45%
6take action top medicines20.30%
7madness who’s profiting from20.30%
8customers in the supply20.30%
9and biosimilar medicines reduce20.30%
10in the supply chain20.30%
11sell it to their20.30%
12resources top medicines examples20.30%
13resources take action top20.30%
14cash generic drug makers20.30%
15examples solutions resources take20.30%
16makers sell it to20.30%
17drug makers sell it20.30%
18generic drug makers sell20.30%
19solutions resources take action20.30%
20examples solutions resources menu20.30%
21savings – developers of10.15%
22– developers of generic10.15%
23developers of generic and10.15%
24of generic and biosimilar10.15%
25and biosimilar medicines rely10.15%
26180day exclusivity period for10.15%
27biosimilar medicines rely on10.15%
28medicines rely on the10.15%
29exclusivity period for new10.15%
30period for new generics10.15%
31for new generics and10.15%
32new generics and the10.15%
33that drive competition and10.15%
34skip to content top10.15%
35tools that drive competition10.15%
36the tools that drive10.15%
37preserve the tools that10.15%
38entry preserve the tools10.15%
39generic entry preserve the10.15%
40earlier generic entry preserve10.15%

EXTERNAL LINKS

# URL Whois Check
1https://accessiblemeds.org/sustainable-markets-report Whoisaccessiblemeds.org
2 https://accessiblemeds.org/sites/default/files/2022-05/FTC-PBM-Business-Practices-05-20-2022_0_0.pdf#new_tab Whoisaccessiblemeds.org
3 https://accessiblemeds.org/sites/default/files/2022-03/AAM-Public-Comments-RFI-Merger-Enforcement-Version-3-18-22.pdf#new_tab Whoisaccessiblemeds.org
4 https://accessiblemeds.org/resources/blog/seniors-are-still-missing-out-savings-medicare-part-d#new_tab Whoisaccessiblemeds.org
5 https://accessiblemeds.org/resources/blog/generic-prices-falling-seniors-paying-more-whats-happening#new_tab Whoisaccessiblemeds.org
6 https://accessiblemeds.org/sites/default/files/2021-10/AAM-2021-US-Generic-Biosimilar-Medicines-Savings-Report-web.pdf#new_tab Whoisaccessiblemeds.org
7 https://accessiblemeds.org/sites/default/files/2020-01/AAM-White-Paper-Substitution-January2020.pdf#new_tab Whoisaccessiblemeds.org
8 https://accessiblemeds.org/sites/default/files/2019-09/AAM-White-Paper-Access-Denied-First-Generics-web_0.pdf#new_tab Whoisaccessiblemeds.org
9 https://www.secureourmeds.org/media/2021/02/AAM-Sustainable-Markets-report.pdf#new_tab Whoissecureourmeds.org
10 https://accessiblemeds.org/campaign/abuse-patent-system-keeping-drug-prices-high-patients#new_tab Whoisaccessiblemeds.org
11 https://accessiblemeds.org/resources/blog/medicaid-generics-penalty-primer-part-1?_ga=2.221506072.1243486949.1646667865-2102300802.1630701966#new_tab Whoisaccessiblemeds.org
12 https://accessiblemeds.org/sites/default/files/2020-02/AAM-White-Paper-Medicare-Part-D-New-Generics-to-Seniors-web.pdf#new_tab Whoisaccessiblemeds.org
13 https://accessiblemeds.org/resources/press-releases/seniors-denied-access-to-generic-drugs-due-to-medicare-coverage#new_tab Whoisaccessiblemeds.org
14 https://www.raps.org/news-and-articles/news-articles/2021/7/aam-medicare-part-d-plans-slow-to-adopt-generics#new_tab Whoisraps.org
15 https://accessiblemeds.org/resources/blog/first-price-cut-steepest#new_tab Whoisaccessiblemeds.org
16 https://accessiblemeds.org/privacy-policy Whoisaccessiblemeds.org
17 https://accessiblemeds.org/aam-terms-use Whoisaccessiblemeds.org